| ALS | Amyotrophic lateral sclerosis |
| AAV | Adeno-associated virus |
| AChR | Acetylcholine receptor |
| Akt | Protein kinase B |
| AMPK | AMP-activated protein kinase |
| ASO | Antisense oligonucleotide |
| ATP | Adenosine triphosphate |
| Ca2+ | Calcium ion |
| CRISPR | Clustered regularly interspaced short palindromic repeats |
| DMD | Duchenne muscular dystrophy |
| EC coupling | Excitation–contraction coupling |
| ECM | Extracellular matrix |
| EVs | Extracellular vesicles |
| FOXO | Forkhead box O transcription factor |
| GMP | Good manufacturing practice |
| HLA | Human leukocyte antigen |
| iMPs | Induced myogenic progenitors |
| iPSCs | Induced pluripotent stem cells |
| MSC | Mesenchymal stromal/stem cell |
| MuSCs | Muscle stem cells (satellite cells) |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NMJ | Neuromuscular junction |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| nNOS/eNOS | Neuronal/endothelial nitric oxide synthase |
| NOX | NADPH oxidase |
| PGC-1α | Peroxisome proliferator-activated receptor gamma coactivator 1-alpha |
| PTP | Permeability transition pore |
| RNA | Ribonucleic acid |
| RONS | Reactive oxygen and nitrogen species |
| RyR1 | Ryanodine receptor type 1 |
| SIRT1 | Sirtuin 1 |
| SMA | Spinal muscular atrophy |
| SOD | Superoxide dismutase |
| UPS | Ubiquitin–proteasome system |